Race: a risk factor for dengue hemorrhagic fever, Arch Virol, vol.152, pp.533-575, 2007. ,
Dengue: a continuing global threat, Nat Rev Microbiol, vol.8, pp.7-16, 2010. ,
Human genetic determinants of dengue virus susceptibility. Microbes and infection, Institut Pasteur, vol.11, pp.143-56, 2009. ,
Combination of CTLA-4 and TGFbeta1 gene polymorphisms associated with dengue hemorrhagic fever and virus load in a dengue-2 outbreak, Clin Immunol, vol.131, pp.404-413, 2009. ,
TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients, Tissue Antigens, vol.64, pp.469-72, 2004. ,
Susceptibility to dengue hemorrhagic fever in vietnam: evidence of an association with variation in the vitamin d receptor and Fc gamma receptor IIa genes, Am J Trop Med Hyg, vol.67, pp.102-108, 2002. ,
Association of human leukocyte antigen DQ1 and dengue fever in a white Southern Brazilian population, Mem Inst Oswaldo Cruz, vol.99, pp.559-62, 2004. ,
A variant in the CD209 promoter is associated with severity of dengue disease, Nat Genet, vol.37, pp.507-520, 2005. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00177402
T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity, J Immunol, vol.168, pp.5959-65, 2002. ,
Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1, Nat Genet, vol.43, pp.1139-1180, 2011. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02069107
Viral encounters with 2?,5?-oligoadenylate synthetase and RNase L during the interferon antiviral response, J Virol, vol.81, pp.12720-12729, 2007. ,
Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases, Exp Mol Med, vol.47, p.144, 2015. ,
The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities, J Interferon Cytokine Res, vol.31, pp.41-48, 2011. ,
OAS proteins and cGAS: unifying concepts in sensing and responding to cytosolic nucleic acids, Nat Rev Immunol, vol.14, pp.521-529, 2014. ,
A nonsense mutation in the gene encoding 2?-5?-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice, Proc Natl Acad Sci U S A, vol.99, pp.11311-11317, 2002. ,
Distinct antiviral roles for human 2?,5?-oligoadenylate synthetase family members against dengue virus infection, J Immunol, vol.183, pp.8035-8078, 2009. ,
Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man, PLoS Pathog, vol.5, p.1000321, 2009. ,
Single nucleotide polymorphisms in genes for 2?-5?-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection, J Infect Dis, vol.192, pp.1741-1749, 2005. ,
Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine, Vaccine, vol.29, pp.8988-97, 2011. ,
Polymorphisms in interferoninduced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR, Genes Immun, vol.4, pp.411-420, 2003. ,
The large form of human 2?,5?-Oligoadenylate Synthetase (OAS3) exerts antiviral effect against Chikungunya virus, Virology, vol.384, pp.216-238, 2009. ,
Constitutive expression of (2?-5?) oligo A synthetase confers resistance to picornavirus infection, Nature, vol.330, pp.587-595, 1987. ,
The expression of both domains of the 69/71 kDa 2?,5? oligoadenylate synthetase generates a catalytically active enzyme and mediates an anti-viral response, Eur J Biochem, vol.262, pp.155-65, 1999. ,
The p59 oligoadenylate synthetase-like protein possesses antiviral activity that requires the C-terminal ubiquitin-like domain, J Gen Virol, vol.89, pp.2767-72, 2008. ,
Polymorphisms in the oligoadenylate synthetase gene cluster and its association with clinical outcomes of dengue virus infection, Infect Genet Evol, vol.14, pp.390-395, 2013. ,
, Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control: New Edition, 2009.
, Dengue hemorrhagic fever: diagnosis, treatment, prevention and control, 1997.
Study of Dengue virus infection in SCID mice engrafted with human K562 cells, J Virol, vol.72, pp.9729-9766, 1998. ,
Arlequin (version 3.0): an integrated software package for population genetics data analysis, Evol Bioinform Online, vol.1, pp.47-50, 2005. ,
, High Anti-DENV Activity of the OAS Gene Family ? JID, vol.2015, p.212, 2019.
Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS), Trans R Soc Trop Med Hyg, vol.81, pp.816-836, 1987. ,
Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study, Am J Trop Med Hyg, vol.42, pp.179-84, 1990. ,
Epidemiology of dengue/dengue hemorrhagic fever in Malaysia-a retrospective epidemiological study. 1973-1987. Part II: Dengue fever (DF), Asia Pac J Public Health, vol.6, pp.126-159, 1992. ,
Epidemiology of dengue/dengue hemorrhagic fever in Malaysia-a retrospective epidemiological study 1973-1987. Part I: Dengue hemorrhagic fever (DHF), Asia Pac J Public Health, vol.6, pp.15-25, 1992. ,
Variation in antiviral 2?,5?-oligoadenylate synthetase (2?5?AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene, Am J Hum Genet, vol.76, pp.623-656, 2005. ,
Structural basis for cytosolic double-stranded RNA surveillance by human oligoadenylate synthetase 1, Proc Natl Acad Sci U S A, vol.110, pp.1652-1659, 2013. ,
2?-5?-Oligoadenylate synthetase is activated by a specific RNA sequence motif, Bioch:em Biophys Res Commun, vol.388, pp.317-339, 2009. ,
Activation of IFN-β expression by a viral mRNA through RNase L and MDA5, Proc Natl Acad Sci U S A, vol.108, pp.2118-2141, 2011. ,
Small self-RNA generated by RNase L amplifies antiviral innate immunity, Nature, vol.448, pp.816-825, 2007. ,
Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus, Proc Natl Acad Sci, vol.103, pp.8459-64, 2006. ,
Dengue virus pathogenesis: an integrated view, Clin Microbiol Rev, vol.22, pp.564-81, 2009. ,
Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms, Nat Rev Immunol, vol.11, pp.532-575, 2011. ,
Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever, FEMS Immunol Med Microbiol, vol.44, pp.43-50, 2005. ,
Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitor reverse transcription-polymerase chain reaction, J Med Virol, vol.63, pp.29-34, 2001. ,
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity, J Infect Dis, vol.181, pp.2-9, 2000. ,
High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis, Virology, vol.305, pp.330-338, 2003. ,
Classical dengue hemorrhagic fever resulting from two dengue infections spaced 20 years or more apart: Havana, dengue 3 epidemic, Int J Infect Dis, vol.9, pp.280-285, 2001. ,
Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission, Am J Trop Med Hyg, vol.65, pp.180-183, 2001. ,